Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; A pilot study

BMC Infectious Diseases

Volumn 1, Issue , 2001, Pages

  Stevceva, Liljana ^a   Tryniszewska, Elzbieta ^a   Hel, Zdenek ^a   Nacsa, Janos ^a   Kelsall, Brian ^b   Parks, Robyn Washington ^a   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL MUCOSA; IMMUNE RESPONSE; IN VITRO STUDY; INOCULATION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE PROLIFERATION; MACACA; NONHUMAN; PERMEABILITY BARRIER; PILOT STUDY; RHESUS MONKEY; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TIME; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; ANIMAL; BLOOD; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL DIVISION; GENETICS; IMMUNOLOGY; MONKEY DISEASE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE MODELS, ANIMAL; MACACA MULATTA; PILOT PROJECTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 19044368258     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-1-9     Document Type: Article

References (43)

1. Farthing C, Gazzard B: Acute illnesses associated with HTLV-III seroconversion. Lancet 1985, 1:935-936
2. McCaul TF, Tovey G, Farthing CF, Gazzard B, Zuckerman AJ: Acute glandular fever-like illness in a patient with HTLV-III antibody. J Med Virol 1985, 17:179-193
3. Valle SL: Febrile pharyngitis as the primary sign of HIV infection in a cluster of cases linked by sexual contact. Scand J Infect Dis 1987, 19:13-17
4. Colebunders R, Greenberg AE, Francis H, Kabote N, Izaley L, Nguyen-Dinh P, et al: Acute HIV illness following blood transfusion in three African children. AIDS 1988, 2:125-127
5. Franceschi S, Tirelli U, Vaccher E, Serraino D, Crovatto M, De Paoli P, et al: Risk factors for HIV infection in drug addicts from the northeast of Italy. Int J Epidemiol 1988, 17:162-167
6. Harms G, Laukamm-Josten U, Bienzle U, Guggenmoos-Holzmann I: Risk factors for HIV infection in German i.v. drug abusers. Clinical, serological and epidemiological features. Klin Wochenschr 1987, 65:376-379
7. Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, et al: Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986, 255:3133-3137
8. Couedel-Courteille A, Butor C, Juillard V, Guillett JG, Venet A: Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers. Virology 1999, 260:277-294
9. Hocini H, Bomsel M: Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J Infect Dis 1999, 179:S448-S453
10. Smith PD, Li L, Meng G: Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection. J Infect Dis 1999, 179:S436-S440
11. Stahl-Hemiig C, Steinman RM, Temier-Racz K, Pope M, Stolte N, Matz-Rensing K, et al: Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999, 285:1261-1265
12. Zhang Z-Q, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al: Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357
13. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MBA: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110
14. Koup RA, Safrit JT, Cao Y, Andrew CA, McLeod G, Borkowsky W, et al: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655
15. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lifton MA, Lord CI, et al: Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999, 162:5127-5133
16. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, et al: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Nati Acad Sci USA 1997, 94:1890-1895
17. Royce RA, Sena A, Cates W Jr, Cohen MS: Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078
18. Lohman BL, Miller CJ, McChesney MB: Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995, 155:5855-5860
19. Mattapallil JJ, Smit-McBride Z, McChesney M, Dandekar S: Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection. J Virol 1998, 72:6421-6429
20. Murphey-Corb M, Wilson LA, Trichel AM, Roberts DE, Xu K, Okhawa S, et al: Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 1999, 162:540-549
21. Westermami J, Persin S, Matyas J, van der Meide P, Pabst R: Migration of so-called naive and memory T lymphocytes from blood to lymph in the rat. The influence of IFN-gamma on the circulation pattern. J Immunol 1994, 152:1744-1750
22. Westermami J, Pabst R: How organ-specific is the migration of 'naive' and 'memory' T cells? Immunol Today 1996, 17:278-282
23. Drayson MT: The entry of lymphocytes into stimulated lymph nodes. The site of selection of alloantigen-specific cells. Transplantation 1986, 41:745-751
24. Stevceva L, Abimiku AG, Franchini G: Targeting the mucosa: genetically engineered vaccines and mucosal immune responses. Genes and Immunity 2000, 1:308-315
25. Lackner AA: Pathology of simian immunodeficiency virus induced disease. Curr Top Microbiol Immunol 1994, 188:35-64
26. Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, Waldron LM, et al: Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230:71-73
27. Letvin NL, King NW: Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr 1990, 3:1023-1040
28. Ringler DJ, Hancock WW, King NW, Letvin NL, Daniel MD, Desrosiers RC, et al: Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome. Am J Pathol 1987, 126:199-207
29. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al: HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000, 97:2709-2714
30. Hel Z, Venzon D, Poudyal M, Tsai W-P, Giuliani L, Woodward R, et al: Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat Med 2000, 6:1140-1146
31. Romano JW, Williams KG, Shurtliff RN, Ginocchio C, Kaplan M: NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol Invest 1997, 26:15-28
32. Allen TM, Mothe BR, Sidney J, Jing P, Dzuris JL, Liebl ME, et al: CD8(+)lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing. J Virol 2001, 75:738-749
33. Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, et al: Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med 1998, 187:1373-1381
34. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, et al: Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274:94-96
35. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothe BR, Vogel TU, et al: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000, 407:386-390
36. Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, et al: Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med 1999, 5:643-650
37. Pauza CD, Trivedi P, Wallace M, Ruckwardt TJ, Le Buanec H, Lu W, et al: Vaccination with tat toxoid attenuates disease in simian/ HIV-challenged macaques. Proc Natl Acad Sci USA 2000, 97:3515-3519
38. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, et al: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431
39. Veazey RS, Tham IC, Mansfield KG, DeMaria M, Forand AE, Shvetz DE et al: Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000, 74:57-64
40. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lord CI, Forman MA, et al: Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J Virol 1999, 73:1573-1579
41. Kewenig S, Schneider T, Hohloch K, Lampe-Dreyer K, Ullrich R, Stolte N, et al: Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999, 116:1115-1123
42. Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham PD, Shearer GM, et al: Recombinant vaccine-induced protection against the highly pathogenic SIVmac251: dependence on route of challenge exposure. J Virol 1998, 72:4170-4182
43. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, et al: Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 1998, 95:3851-3856